Markets in Focus

Life Sciences

Q4 2022

Markets in Focus  |  Life Sciences  | Life Sciences Q4 2022

Life Science companies are at the forefront of innovation, with a unique set of challenges when it comes to insurance. The global pandemic highlighted how important these industries really are and drove them forward in ways we haven’t seen before; large amounts spent on research and development by private firms as well as through federal government. The rise in R&D expenditure across the Life Science sector will continue to drive industry growth.

This edition covers:

+ 2H Outlook

+ Major Claims in the Sector

+ Guidance